Podcasts
Cancer Conversations Podcast – Episode #4: The Latest Research in Multiple Myeloma and Leukemia

With new research in immunotherapy and targeted therapy, treatment options for blood cancer patients are rapidly expanding. Combination therapies have also caused much excitement among researchers and physicians, and ongoing clinical trials are continuing to look at new strategies that use multiple drugs for fighting these diseases. In this Cancer […]

February 26, 2016
0
Cancer research
The Latest Research in Multiple Myeloma, Leukemia and Other Blood Cancers

The last two years have been very exciting for blood cancer research; many new targeted therapies and immunotherapies are improving treatment outcomes for patients with lymphoma, leukemia and multiple myeloma. “We’re starting to see a lot of hematologic malignancies benefit from immunotherapy,” says Irene Ghobrial, MD. “The excitement is there […]

February 11, 2016
0
Care for adults
What’s New in Research for Blood Cancer Treatments?

The past two years have seen a surge of new treatments for blood cancers, such as lymphoma, leukemia and multiple myeloma. Research on the genetic flaws underlying specific cancer types has led to new precision drugs such as ibrutinib and idelalisib and new immunotherapy agents that are improving outcomes in […]

September 30, 2015
2
Cancer research
Know Your Surroundings: How Cancer Treatments Can Keep Cells From Supporting Tumors

By Eric Bender Multiple myeloma is a poster child for recent advances in treatment: In the past decade, the U.S. Food and Drug Administration (FDA) approved no fewer than nine treatments for the blood cancer, and several more drug approvals appear to be near. Not coincidentally, multiple myeloma is also […]

June 19, 2015
2
Cancer research
From Foe to Friend: Viruses Show New Promise as Cancer Treatment

Updated Oct. 28, 2015 Almost as long as scientists have known of the existence of viruses, they’ve dreamed of using the tiny pathogens as a weapon against cancer. Now, as a result of advances in genetic engineering and insights into the workings of the immune system, science is giving substance […]

May 1, 2015
0
Care for adults , General interest
Remembering My Father’s Journey with Multiple Myeloma

By Elise Renner There’s a 1-in-12 chance that this is the month yours or your loved one’s cancer is recognized—odds better than the survival rates for some of these diseases. Some months, like October, boast big names like breast cancer. Others, like September, are crowded with lesser-known branches of the […]

March 23, 2015
30
General interest
Tuukka Rask, Nutrition Tips, Brokaw on Cancer, and More Video Highlights from 2014

As 2014 comes to a close, we’re taking a look back at some of our favorite videos from the last year:     Tom Brokaw: What it Means to Have Cancer NBC News’ Tom Brokaw, who was diagnosed with multiple myeloma in August 2013, stopped by Dana-Farber in November. We […]

December 30, 2014
0
Cancer research
The Latest Research and Treatment for Blood Cancers and Disorders

In the treatment of blood cancers and disorders, doctors and researchers are focusing their sights on the immune system and how to bolster its ability to fight off diseases like leukemia, lymphoma and multiple myeloma. “Understanding how you control the immune system is a big theme in treatment for these […]

December 26, 2014
0
Care for adults
Tips and Advice for Taking Oral Chemotherapy

By Thomas Kochanek, PhD When we think of chemotherapy, most of us imagine a cancer patient hooked up to an IV in a hospital setting, getting his or her treatment through infusion. While this image is accurate, cancer treatment increasingly takes place at home, as patients receive oral chemotherapy or other […]

December 12, 2014
2
Care for adults , General interest
Tom Brokaw: What It Means to Have Cancer

Tom Brokaw (left) meets with Dana-Farber President and CEO Edward J. Benz, Jr., MD. The world is divided between those who are sympathetic to their friends and family who have cancer and those who have cancer and are empathetic with each other, says Tom Brokaw, the former “NBC Nightly News” […]

November 25, 2014
13
General interest
Tackling College, Marathons, and Multiple Myeloma

By Ethan Hawes “Having cancer in college doesn’t seem real.” That was my first thought when I received what would become life-changing news at the age of 22 as a senior at the University of Maine (Orono). My body went numb and tears started to form when my doctor told […]

November 12, 2014
9
Care for adults
New Clinic Focuses on Why Some Conditions Become Cancer While Others Don’t

Thousands of people learn each year – usually after a routine blood test – that they have a condition that may develop into a blood cancer such as leukemia, lymphoma or multiple myeloma. The news is often followed by an equally surprising addendum: the condition won’t be treated until it […]

October 22, 2014
1
Cancer research
Research Advances Hold Promise for Multiple Myeloma Treatment

Multiple myeloma is one of the most compelling examples of a cancer in which research has markedly improved the length and quality of patients’ lives in the last decade. A malignancy of certain white blood cells in the bone marrow known as plasma cells, myeloma is still considered incurable, but treatment […]

July 28, 2014
1
Care for adults , Care for children
How a Port Can Make Cancer Treatments Easier

For more than five years, Sally Boyd had repeated needle punctures in her arm for blood draws, chemotherapy, and other procedures for multiple myeloma. “The nurses said I had good veins, so at first it was easy for them to insert the needle,” Boyd recalls. “But as time went on, […]

April 14, 2014
1
Care for adults , Health and wellness
Does Cancer Cause Blood Clots?

Cancer patients are at a higher risk than the general population of developing serious blood clots, including deep vein thrombosis (DVT) in the legs or pulmonary emboli in the lungs, which can be fatal.

April 4, 2014
1
Cancer research
A History of Multiple Myeloma Advances

Not long ago, a diagnosis of multiple myeloma — a cancer of the bone marrow — carried with it a very poor prognosis, with median survival estimates of just two to three years. Now, thanks in large part to research and treatment advances at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), […]

February 24, 2014
7
Cancer research , Care for adults
Brokaw Diagnosis: What is Multiple Myeloma?

NBC News’ Tom Brokaw, 74, revealed this week he has multiple myeloma, a cancer of the bone marrow. The disease, also known as plasma cell myeloma, will be diagnosed in more than 24,000 Americans this year.

February 12, 2014
3
Care for adults , General interest
How Donated Blood and Platelets Help Cancer Patients

If you’ve ever donated blood or platelets, there’s a reasonable chance that your donation went to help a cancer patient. That’s because cancer and certain treatments can damage blood cells, which means some patients may need transfusions of one or more types of blood components:

January 24, 2014
1
Care for adults , Care for children , General interest
What’s the Difference Between Donating Bone Marrow and Donating Stem Cells?

Stem cell transplantation (sometimes called bone marrow transplants) is a treatment for certain forms of cancer, such as leukemia, lymphoma, and multiple myeloma, as well as other diseases. But before a patient can receive a transplant, stem cells must be collected from a donor (an allogeneic donation) or from the […]

November 22, 2013
1
Care for adults
New Therapies Bring Progress Against Multiple Myeloma

By Christine Cleary  The 21st century has seen great strides in treatment for multiple myeloma, a cancer of the bone marrow once considered a death sentence. In fact, thanks to research by Dana-Farber scientists, this blood cancer that took the lives of Geraldine Ferraro and Leonard P. Zakim has become […]

July 18, 2013
21
Care for adults , Health and wellness
Seven Tips for Life After Stem Cell Transplant

By Maria Pearson As a technology teacher who had a long career with IBM before going into education, I have encountered all sorts of opportunities to teach – and to learn. The biggest such opportunity of my life occurred at the intersection of cancer, technology, and Dana-Farber. In August 2010, […]

February 20, 2013
21
Cancer research
Making Science Count: A Conversation with Ken Anderson

When Ken Anderson, MD, began working on multiple myeloma four decades ago, the disease, a cancer of the bone marrow, was untreatable. “People died within months,” says Anderson. Today, the story is very different. In the past decade, eight new multiple myeloma treatments have been approved. Survival has doubled. “When […]

November 29, 2012
1
Cancer research , Care for adults
A Life Saved by Second Opinions, Experimental Treatments, and a Touch of Luck

By James Bond “How long will I live?” I asked my oncologist in Ohio in 1992, when I was 44 and diagnosed with multiple myeloma. “Three years,” he answered. Instead, I enjoyed 10 more years of active living. Then my disease began to overtake me; my kidneys were failing, I […]

May 3, 2012
13

Latest Tweets

Dana-Farber @danafarber
Cervical cancer is most common in Hispanic women, followed by African-American wmn. https://t.co/oH8K8g6Hht #NMHM16 https://t.co/pSeJzHwIzr
Dana-Farber @danafarber
RT @PGameHD: Simple 2 min explanation of #TesticularCancer detection & treatment. Worth watching #TCisNoJoke #BWH https://t.co/W13oy90KUi
Dana-Farber @danafarber
RT @chemobrainfog: What a joy to see my sister and my friend, Kwanele speaking @DanaFarber at #GHCS16. She changes lives EVERY DAY. https:/…

Make An Appointment

For adults: 877-442-3324

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.